Agilent to Acquire North American CDMO BIOVECTRA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Jefferies Reiterates Hold Rating on Agilent (A)
July 22, 2024 12:42 PM EDTJefferies analyst Brandon Couillard reiterated a Hold rating and $135.00 price target on Agilent (NYSE: A).
The analyst comments "Agilent's move to acquire BIOVECTRA ($925M, or ~7x '24 revenues) would expand exposure to specialized CDMO market, adding PDNA, mRNA and HPAPI capabilities to... More
